{
    "nctId": "NCT04800393",
    "briefTitle": "The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.",
    "officialTitle": "The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial (TeMP - Trial).",
    "overallStatus": "RECRUITING",
    "conditions": "Anesthesia, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 130,
    "primaryOutcomeMeasure": "Neutrophil-lymphocyte ratio",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* The age of the patients is from 45 to 74 years;\n* Primary operable breast cancer (BC) without prior chemotherapy;\n* Cytologically confirmed breast malignant tumor of IA-IIA stages (T1-2, N0, M0);\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Acute cerebrovascular accident (CVA) occurred in the previous 6 months;\n* Myocardial infarction (MI) occurred in the previous 6 months;\n* Acute arterial thrombosis occurred in the previous 6 months;\n* Acute venous thromboembolism occurred in the previous 6 months;\n* Subarachnoid hemorrhage occurred during the previous 3 months;\n* Chronic kidney disease (CKD) stage 3B-5;\n* \u0421hronic heart failure (NYHA) class 3-4;\n* Pregnancy;\n* History of another location cancer;\n* History of drug addiction;\n* Autoimmune diseases in history;\n* Post-randomization: withdrawal of informed consent (refusal to continue participating in the study);\n* Post-randomization: surgical intervention, performed not in full (verified non-resected lesions in the early p/o period, 2 weeks p/o).",
    "sex": "FEMALE",
    "minimumAge": "45 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}